--- title: "The pharmaceutical sector strengthens with multiple stocks rising over 10%" type: "News" locale: "en" url: "https://longbridge.com/en/news/236507108.md" description: "The pharmaceutical sector strengthened, with multiple stocks rising over 10%. Kingchem hit a 20% limit up, Oucan Pharmaceutical rose over 17%, Staidson BioPharm increased over 11%, Lifeon Pharmaceutical hit the limit up, and Deyuan Pharmaceutical, BHC, and others surged" datetime: "2025-04-18T01:41:21.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/236507108.md) - [en](https://longbridge.com/en/news/236507108.md) - [zh-HK](https://longbridge.com/zh-HK/news/236507108.md) generator: "portal-rs" --- # The pharmaceutical sector strengthens with multiple stocks rising over 10% The pharmaceutical sector strengthened, with multiple stocks rising over 10%. Kingchem surged 20% to the daily limit, Oucan Pharmaceutical rose over 17%, Staidson BioPharm increased over 11%, Lifeon Pharmaceutical hit the daily limit, and Deyuan Pharmaceutical, BHC, and others saw significant gains ### Related Stocks - [600721.CN](https://longbridge.com/en/quote/600721.CN.md) - [301509.CN](https://longbridge.com/en/quote/301509.CN.md) - [300204.CN](https://longbridge.com/en/quote/300204.CN.md) - [003020.CN](https://longbridge.com/en/quote/003020.CN.md) ## Related News & Research - [Chinese Pharma Companies Plan Hong Kong Listings](https://longbridge.com/en/news/297979501.md) - [Dogwood Therapeutics highlights Halneuron Phase 2b data readout timeline for chemotherapy-induced neuropathic pain program](https://longbridge.com/en/news/298049944.md) - [Former Bamboo Airways chairman barred from leaving Vietnam over $1.7M tax debt](https://longbridge.com/en/news/298122465.md) - [06:00 ETBest Hair Growth Products for Men (2026): Happy Head Personalized Formulas Reviewed by Consumer365](https://longbridge.com/en/news/298108217.md) - [Healey faces off against Minogue in quest for second term as Massachusetts governor](https://longbridge.com/en/news/297713455.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**